Shete Harshad K, Prabhu Rashmi H, Patravale Vandana B
J Nanosci Nanotechnol. 2014 Jan;14(1):460-74. doi: 10.1166/jnn.2014.9082.
With advances in therapeutic science, apart from drugs, newer bioactive moieties like oligonucleotides, proteins, peptides, enzymes and antibodies are constantly being introduced for the betterment of therapeutic efficacy. These moieties have intracellular components of the cells like cytoplasm and nucleus as one of their pharmacological sites for exhibiting therapeutic activity. Despite their promising efficacy, their intracellular bioavailability has been critically hampered leading to failure in the treatment of numerous diseases and disorders. The endosomal uptake pathway is known to be a rate-limiting barrier for such systems. Bioactive molecules get trapped in the endosomal vesicles and degraded in the lysosomal compartment, necessitating the need for effective strategies that facilitate the endosomal escape and enhance the cytosolic bioavailability of bioactives. Microbes like viruses and bacteria have developed their innate mechanistic tactics to translocate their genome and toxins by efficiently penetrating the host cell membrane. Understanding this mechanism and exploring it further for intracellular delivery has opened new avenues to surmount the endosomal barrier. These strategies include membrane fusion, pore formation and proton sponge effects. On the other hand, progress in designing a novel smart polymeric carrier system that triggers endosomal escape by undergoing modulations in the intracellular milieu has further led to an improvement in intracellular delivery. These comprise pH, enzyme and temperature-induced modulators, synthetic cationic lipids and photo-induced physical disruption. Each of the aforementioned strategies has its own unique mechanism to escape the endosome. This review recapitulates the numerous strategies designed to surmount the bottleneck of endosomal escape and thereby achieve successful intracellular uptake of bioactives.
随着治疗科学的进步,除了药物之外,像寡核苷酸、蛋白质、肽、酶和抗体等更新的生物活性部分不断被引入以提高治疗效果。这些部分将细胞的细胞内成分如细胞质和细胞核作为其发挥治疗活性的药理学部位之一。尽管它们具有有前景的疗效,但其细胞内生物利用度受到严重阻碍,导致在治疗众多疾病和病症时失败。已知内体摄取途径是此类系统的限速屏障。生物活性分子被困在内体小泡中并在溶酶体区室中降解,因此需要有效的策略来促进内体逃逸并提高生物活性物质的胞质生物利用度。像病毒和细菌这样的微生物已经发展出它们固有的机制策略,通过有效穿透宿主细胞膜来转运其基因组和毒素。理解这种机制并进一步探索其用于细胞内递送,为克服内体屏障开辟了新途径。这些策略包括膜融合、孔形成和质子海绵效应。另一方面,设计一种新型智能聚合物载体系统的进展,该系统通过在细胞内环境中进行调节来触发内体逃逸,进一步导致细胞内递送得到改善。这些包括pH、酶和温度诱导的调节剂、合成阳离子脂质和光诱导的物理破坏。上述每种策略都有其独特的内体逃逸机制。本综述概述了为克服内体逃逸瓶颈从而实现生物活性物质成功细胞内摄取而设计的众多策略。